Stay updated on Safety of CVL-231 in Schizophrenia: Clinical Trial
Sign up to get notified when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.

Latest updates to the Safety of CVL-231 in Schizophrenia: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe study page revision stamp was updated to v3.5.3, replacing v3.5.2, indicating a minor metadata update to the entry.SummaryDifference0.0%

- Check19 days agoChange DetectedAdded a “Schizophrenia” related topics reference for MedlinePlus Genetics. This updates supplementary navigation/content links without affecting the study’s main information.SummaryDifference0.1%

- Check26 days agoChange DetectedRevision: v3.5.2 is now displayed on the page, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check33 days agoChange DetectedAdded Schizophrenia as a condition and related topics: MedlinePlus Genetics to the study page.SummaryDifference0.1%

- Check48 days agoChange DetectedThe Conditions section no longer lists Schizophrenia or the related MedlinePlus Genetics topic.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Safety of CVL-231 in Schizophrenia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of CVL-231 in Schizophrenia: Clinical Trial page.